Drugs / DermaPure®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03939715 Comparator | Apr 2020 → May 2022 | pelvic organ prolapse | Colorado Pelvic Floor Consultants | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DermaPure | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03939715 ↗ |
| Modality | Other / unclassified | “decellularized human dermal allograft (DermaPure®)” NCT03939715 ↗ |